Privia Health Group, Inc.

The current price of PRVA is $24.42 — it has increased by 2.01% since the previous close. Data as of Nov 6, 2026.

PRVA is up 11.86% over the past week, up 20.30% over the past month and up 4.23% over the past year. The price is above its 200-day moving average of $22.64.

Analysts' average 12-month price target for PRVA is $28.00, which implies 14.66% upside from the current price. Individual estimates range from $24.00 to $32.00.

Of the 18 analysts covering Privia Health Group, Inc., 5 rate it a strong buy, 12 rate it a buy and 1 rates it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

Privia Health Group, Inc. has a market capitalization of $3.12B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, Privia Health Group, Inc. posted earnings of $0.21 per share against an estimate of $0.09048, beating expectations by 132.10%. Upcoming reports are listed in the earnings calendar.

Privia Health Group, Inc. reported revenue of $656.96M in its most recent quarter, which has increased by 13.19% compared with the same quarter a year earlier. Analysts had expected $610.72M.

Privia Health Group, Inc. has not paid any dividends over the past year.

In the latest trading session PRVA moved between $23.66 and $24.45, a range of 3.24% of its current price.

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Privia Health Group, Inc. shows a strong buy rating today and a strong buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Privia Health Group, Inc. is buy. Technical ratings are indicators, not investment advice.

Over the past 52 weeks PRVA has traded between $18.92 and $28.82. The current price is 15.27% below its 52-week high.